Janux Therapeutics, Inc.

NASDAQ:JANX

48.32 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 14.662212.80319.20517.15233.70330.35551.42664.75258.40355.12935.58239.389251.62570.7697.813-0.658
Short Term Investments 631.631438.96324.823332.56269.586286.52275.59274.008295.893306.071339.383348.118142.57001.316
Cash and Short Term Investments 646.293651.763344.028349.712303.289316.875327.016338.76354.296361.2374.965387.507394.19570.7697.8130.658
Net Receivables 12.0564.4052.21.71.50.750.70.50.30.10.20.0280.3750.37580
Inventory 00-2.2-1.7-1.50-0.70-0.3-0.1-0.2-0.0280000
Other Current Assets 3.592.4985.2135.4836.0133.7745.4235.073.7693.4542.0542.0812.0380.2620.2490
Total Current Assets 661.939658.666349.241355.195309.302321.399332.439344.33358.065364.654377.019389.588396.60871.40616.0620.658
Non-Current Assets:
Property, Plant & Equipment, Net 26.01726.97827.84128.52528.94929.1329.36529.17726.2772.791.5971.3560.2150.1560.1550
Goodwill 0000000000000000
Intangible Assets 0000000000000000
Goodwill and Intangible Assets 0000000000000000
Long Term Investments 0.8160.8160.8160.8160.8160.8160.8160.8160.8160.816339.38300000
Tax Assets 0000000000000000
Other Non-Current Assets 2.642.5242.5092.3142.4331.6111.391.4330.2070.337-338.1750.1400.2570-0.658
Total Non-Current Assets 29.47330.31831.16631.65532.19831.55731.57131.42627.33.9432.8051.4960.2150.4130.155-0.658
Total Assets 691.412688.984380.407386.85341.5352.956364.01375.756385.365368.597379.824391.084396.82371.81916.2170
Liabilities & Equity:
Current Liabilities:
Account Payables 1.2532.2542.4242.5051.912.0512.1592.86631.9392.4583.6130.3540.8570.4280
Short Term Debt 1.631.5731.5171.4621.4081.3560.76300.0880.1530.1940.2122.2860.7210.7510
Tax Payables 0000000000000000
Deferred Revenue 0.0940.9721.7053.6485.344.9355.4065.9065.3714.6495.1635.2645.0653.6461.950
Other Current Liabilities 8.5685.817.3876.8569.2467.7728.1797.5634.5355.7744.9823.3821.51.670.0520
Total Current Liabilities 11.54510.60913.03314.47117.90416.11416.50716.33512.99412.51512.79712.4719.2056.8943.1810
Non-Current Liabilities:
Long Term Debt 22.1922.61223.02523.43123.8224.18424.54224.09223.26800.1940.0230000
Deferred Revenue Non-Current 00000.3071.3942.2213.8165.28900.71.842.8234.356.050
Deferred Tax Liabilities Non-Current 0000-0.307-1.394-2.221-3.816-5.28900-1.840000
Other Non-Current Liabilities -0-0000.3071.3942.2213.8165.2896.741-0.1940077.34621.6240
Total Non-Current Liabilities 22.1922.61223.02523.43124.12725.57826.76327.90828.5576.7410.71.8632.82381.69627.6740
Total Liabilities 33.73533.22136.05837.90242.03141.69243.2744.24341.55112.51513.49714.33412.02888.5930.8550
Equity:
Preferred Stock 00000000000391.084396.82377.34621.6243.996
Common Stock 0.0520.0510.0460.0460.0420.0420.0420.0420.0420.0410.0410.0410.0410.0010.0010
Retained Earnings -189.482-183.523-168.763-157.005-145.437-127.929-110.47-94.405-77.709-60.821-47.411-33.995-23.229-17.023-14.7390
Accumulated Other Comprehensive Income/Loss -1.616-0.5240.665-1.175-1.06-0.739-1.535-2.277-1.907-1.567-0.270.0240.017-00-7.944
Other Total Stockholders Equity 848.723839.759512.401507.082445.924439.89432.703428.153423.388418.429413.96719.59611.143-77.095-21.5240
Total Shareholders Equity 657.677655.763344.349348.948299.469311.264320.74331.513343.814356.082366.327376.75384.795-16.771-14.638-3.948
Total Equity 657.677655.763344.349348.948299.469311.264320.74331.513343.814356.082366.327376.75384.795-16.771-14.638-3.948
Total Liabilities & Shareholders Equity 691.412688.984380.407386.85341.5352.956364.01375.756385.365368.597379.824391.084396.82371.81916.217-3.948